APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intestinal Anti-infective Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Research

Intestinal Anti-infective Drugs Industry Research Report 2026

27 December 2025145 pages

Choose your research edition.

Industry ResearchIntestinal Anti-infective Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Intestinal Anti-infective Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Intestinal Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intestinal Anti-infective Drugs Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Intestinal Anti-infective Drugs Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Intestinal Anti-infective Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Intestinal Anti-infective Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Intestinal Anti-infective Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Intestinal Anti-infective Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Intestinal Anti-infective Drugs include Chongqing Sino Biopharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Zhejiang Deer Pharmaceutical Co., Ltd., Yunnan Weihe Pharmaceutical Co., Ltd., Yangzhou Sanyao Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Teyi Pharmaceutical Group Co., Ltd., Sichuan Ziligong Pharmaceutical Co., Ltd. and Shaanxi Kaiyuan Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Intestinal Anti-infective Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Intestinal Anti-infective Drugs Market by Company

Chongqing Sino Biopharmaceutical Co., Ltd.

Chongqing Laimi Pharmaceutical Co., Ltd.

Zhejiang Deer Pharmaceutical Co., Ltd.

Yunnan Weihe Pharmaceutical Co., Ltd.

Yangzhou Sanyao Pharmaceutical Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd.

Teyi Pharmaceutical Group Co., Ltd.

Sichuan Ziligong Pharmaceutical Co., Ltd.

Shaanxi Kaiyuan Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Co., Ltd.

Nanjing Chengong Pharmaceutical Co., Ltd.

Lingyuan Pharmaceutical Co., Ltd.

Jiangxi Pharmaceutical Co., Ltd.

Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.

Jilin Jibang Pharmaceutical Co., Ltd.

Jilin Fukang Pharmaceutical Co., Ltd.

Hubei Hendi Pharmaceutical Co., Ltd.

Hainan Hailing Chemical Pharmaceutical Co., Ltd.

Fujian Sanming Tiantai Pharmaceutical Co., Ltd.

Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.

Vox Nutrition

Teva Pharmaceuticals

Salix Pharmaceuticals

Otto Chemie Pvt Ltd

Medikonda Nutrients

Botanic Healthcare

AdvaCare Pharma

Intestinal Anti-infective Drugs Segment by Type

Neomycin

Berberine

Rifaximin

Intestinal Anti-infective Drugs Segment by Application

Pharmacy

Hospital

Clinic

Other

Intestinal Anti-infective Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intestinal Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intestinal Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intestinal Anti-infective Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Intestinal Anti-infective Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Intestinal Anti-infective Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Intestinal Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Intestinal Anti-infective Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Intestinal Anti-infective Drugs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Intestinal Anti-infective Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Intestinal Anti-infective Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Intestinal Anti-infective Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Intestinal Anti-infective Drugs Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Intestinal Anti-infective Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Intestinal Anti-infective Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Intestinal Anti-infective Drugs, Product Type & Application Table 14. Global Intestinal Anti-infective Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Intestinal Anti-infective Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information Table 19. Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview Table 20. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 22. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments Table 23. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 24. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 25. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 27. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments Table 28. Zhejiang Deer Pharmaceutical Co., Ltd. Company Information Table 29. Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview Table 30. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 32. Zhejiang Deer Pharmaceutical Co., Ltd. Recent Developments Table 33. Yunnan Weihe Pharmaceutical Co., Ltd. Company Information Table 34. Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview Table 35. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 37. Yunnan Weihe Pharmaceutical Co., Ltd. Recent Developments Table 38. Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information Table 39. Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview Table 40. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 42. Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments Table 43. Tiansheng Pharmaceutical Group Co., Ltd. Company Information Table 44. Tiansheng Pharmaceutical Group Co., Ltd. Business Overview Table 45. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 47. Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments Table 48. Teyi Pharmaceutical Group Co., Ltd. Company Information Table 49. Teyi Pharmaceutical Group Co., Ltd. Business Overview Table 50. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 52. Teyi Pharmaceutical Group Co., Ltd. Recent Developments Table 53. Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information Table 54. Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview Table 55. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 57. Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Developments Table 58. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information Table 59. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview Table 60. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 62. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments Table 63. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information Table 64. Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview Table 65. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 67. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments Table 68. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information Table 69. Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview Table 70. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 72. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments Table 73. Lingyuan Pharmaceutical Co., Ltd. Company Information Table 74. Lingyuan Pharmaceutical Co., Ltd. Business Overview Table 75. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 77. Lingyuan Pharmaceutical Co., Ltd. Recent Developments Table 78. Jiangxi Pharmaceutical Co., Ltd. Company Information Table 79. Jiangxi Pharmaceutical Co., Ltd. Business Overview Table 80. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 82. Jiangxi Pharmaceutical Co., Ltd. Recent Developments Table 83. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information Table 84. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview Table 85. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 87. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments Table 88. Jilin Jibang Pharmaceutical Co., Ltd. Company Information Table 89. Jilin Jibang Pharmaceutical Co., Ltd. Business Overview Table 90. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 92. Jilin Jibang Pharmaceutical Co., Ltd. Recent Developments Table 93. Jilin Fukang Pharmaceutical Co., Ltd. Company Information Table 94. Jilin Fukang Pharmaceutical Co., Ltd. Business Overview Table 95. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 97. Jilin Fukang Pharmaceutical Co., Ltd. Recent Developments Table 98. Hubei Hendi Pharmaceutical Co., Ltd. Company Information Table 99. Hubei Hendi Pharmaceutical Co., Ltd. Business Overview Table 100. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 102. Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments Table 103. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information Table 104. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview Table 105. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 107. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments Table 108. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information Table 109. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview Table 110. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 112. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Developments Table 113. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information Table 114. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview Table 115. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio Table 117. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments Table 118. Vox Nutrition Company Information Table 119. Vox Nutrition Business Overview Table 120. Vox Nutrition Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio Table 122. Vox Nutrition Recent Developments Table 123. Teva Pharmaceuticals Company Information Table 124. Teva Pharmaceuticals Business Overview Table 125. Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 127. Teva Pharmaceuticals Recent Developments Table 128. Salix Pharmaceuticals Company Information Table 129. Salix Pharmaceuticals Business Overview Table 130. Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio Table 132. Salix Pharmaceuticals Recent Developments Table 133. Otto Chemie Pvt Ltd Company Information Table 134. Otto Chemie Pvt Ltd Business Overview Table 135. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio Table 137. Otto Chemie Pvt Ltd Recent Developments Table 138. Medikonda Nutrients Company Information Table 139. Medikonda Nutrients Business Overview Table 140. Medikonda Nutrients Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio Table 142. Medikonda Nutrients Recent Developments Table 143. Botanic Healthcare Company Information Table 144. Botanic Healthcare Business Overview Table 145. Botanic Healthcare Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio Table 147. Botanic Healthcare Recent Developments Table 148. AdvaCare Pharma Company Information Table 149. AdvaCare Pharma Business Overview Table 150. AdvaCare Pharma Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio Table 152. AdvaCare Pharma Recent Developments Table 153. Global Intestinal Anti-infective Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 154. Global Intestinal Anti-infective Drugs Sales by Region (2021-2026) & (K Units) Table 155. Global Intestinal Anti-infective Drugs Sales Market Share by Region (2021-2026) Table 156. Global Intestinal Anti-infective Drugs Sales by Region (2027-2032) & (K Units) Table 157. Global Intestinal Anti-infective Drugs Sales Market Share by Region (2027-2032) Table 158. Global Intestinal Anti-infective Drugs Revenue by Region (2021-2026) & (US$ Million) Table 159. Global Intestinal Anti-infective Drugs Revenue Market Share by Region (2021-2026) Table 160. Global Intestinal Anti-infective Drugs Revenue by Region (2027-2032) & (US$ Million) Table 161. Global Intestinal Anti-infective Drugs Revenue Market Share by Region (2027-2032) Table 162. North America Intestinal Anti-infective Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. North America Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 164. North America Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 165. North America Intestinal Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 166. North America Intestinal Anti-infective Drugs Revenue by Country (2027-2032) & (US$ Million) Table 167. Europe Intestinal Anti-infective Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Europe Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 169. Europe Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 170. Europe Intestinal Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 171. Europe Intestinal Anti-infective Drugs Revenue by Country (2027-2032) & (US$ Million) Table 172. Asia Pacific Intestinal Anti-infective Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. Asia Pacific Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 174. Asia Pacific Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 175. Asia Pacific Intestinal Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 176. Asia Pacific Intestinal Anti-infective Drugs Revenue by Country (2027-2032) & (US$ Million) Table 177. South America Intestinal Anti-infective Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. South America Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 179. South America Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 180. South America Intestinal Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 181. South America Intestinal Anti-infective Drugs Revenue by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 183. Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country (2021-2026) & (US$ Million) Table 186. Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country (2027-2032) & (US$ Million) Table 187. Global Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units) Table 188. Global Intestinal Anti-infective Drugs Sales by Type (2027-2032) & (K Units) Table 189. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026) Table 190. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2027-2032) Table 191. Global Intestinal Anti-infective Drugs Revenue by Type (2021-2026) & (US$ Million) Table 192. Global Intestinal Anti-infective Drugs Revenue by Type (2027-2032) & (US$ Million) Table 193. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2026) Table 194. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2027-2032) Table 195. Global Intestinal Anti-infective Drugs Price by Type (2021-2026) & (US$/Unit) Table 196. Global Intestinal Anti-infective Drugs Price by Type (2027-2032) & (US$/Unit) Table 197. Global Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units) Table 198. Global Intestinal Anti-infective Drugs Sales by Application (2027-2032) & (K Units) Table 199. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2026) Table 200. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2027-2032) Table 201. Global Intestinal Anti-infective Drugs Revenue by Application (2021-2026) & (US$ Million) Table 202. Global Intestinal Anti-infective Drugs Revenue by Application (2027-2032) & (US$ Million) Table 203. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2021-2026) Table 204. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2027-2032) Table 205. Global Intestinal Anti-infective Drugs Price by Application (2021-2026) & (US$/Unit) Table 206. Global Intestinal Anti-infective Drugs Price by Application (2027-2032) & (US$/Unit) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Intestinal Anti-infective Drugs Distributors List Table 210. Intestinal Anti-infective Drugs Customers List Table 211. Intestinal Anti-infective Drugs Industry Trends Table 212. Intestinal Anti-infective Drugs Industry Drivers Table 213. Intestinal Anti-infective Drugs Industry Restraints Table 214. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Intestinal Anti-infective Drugs Product Image Figure 5. Global Intestinal Anti-infective Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Intestinal Anti-infective Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Intestinal Anti-infective Drugs Sales (2021-2032) & (K Units) Figure 8. Global Intestinal Anti-infective Drugs Average Price (US$/Unit) & (2021-2032) Figure 9. Neomycin Product Image Figure 10. Berberine Product Image Figure 11. Rifaximin Product Image Figure 12. Pharmacy Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Other Product Image Figure 16. Global Intestinal Anti-infective Drugs Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Intestinal Anti-infective Drugs, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Intestinal Anti-infective Drugs Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Intestinal Anti-infective Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Intestinal Anti-infective Drugs Sales by Region in 2025 Figure 22. Global Intestinal Anti-infective Drugs Revenue by Region in 2025 Figure 23. North America Intestinal Anti-infective Drugs Market Size by Country in 2025 Figure 24. North America Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 25. North America Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2032) Figure 26. United States Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Intestinal Anti-infective Drugs Market Size by Country in 2025 Figure 30. Europe Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 31. Europe Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2032) Figure 32. Germany Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Intestinal Anti-infective Drugs Market Size by Country in 2025 Figure 43. Asia Pacific Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2032) Figure 45. China Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Intestinal Anti-infective Drugs Market Size by Country in 2025 Figure 54. South America Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 55. South America Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2032) Figure 56. Brazil Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Intestinal Anti-infective Drugs Market Size by Country in 2025 Figure 60. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2032) Figure 62. Egypt Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Intestinal Anti-infective Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2032) Figure 68. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2032) Figure 69. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Type (2021-2032) Figure 70. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2032) Figure 71. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2021-2032) Figure 72. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Application (2021-2032) Figure 73. Intestinal Anti-infective Drugs Value Chain Figure 74. Intestinal Anti-infective Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Intestinal Anti-infective Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • Neomycin
  • Berberine
  • Rifaximin
Applications
  • Pharmacy
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Sino Biopharmaceutical Co., Ltd.
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Zhejiang Deer Pharmaceutical Co., Ltd.
  • Yunnan Weihe Pharmaceutical Co., Ltd.
  • Yangzhou Sanyao Pharmaceutical Co., Ltd.
  • Tiansheng Pharmaceutical Group Co., Ltd.
  • Teyi Pharmaceutical Group Co., Ltd.
  • Sichuan Ziligong Pharmaceutical Co., Ltd.
  • Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Nanjing Chengong Pharmaceutical Co., Ltd.
  • Lingyuan Pharmaceutical Co., Ltd.
  • Jiangxi Pharmaceutical Co., Ltd.
  • Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  • Jilin Jibang Pharmaceutical Co., Ltd.
  • Jilin Fukang Pharmaceutical Co., Ltd.
  • Hubei Hendi Pharmaceutical Co., Ltd.
  • Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  • Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  • Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  • Vox Nutrition
  • Teva Pharmaceuticals
  • Salix Pharmaceuticals
  • Otto Chemie Pvt Ltd
  • Medikonda Nutrients
  • Botanic Healthcare
  • AdvaCare Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Intestinal Anti-infective Drugs Market Size (2021-2032)
  4. 2.2.2 Global Intestinal Anti-infective Drugs Sales (2021-2032)
  5. 2.2.3 Global Intestinal Anti-infective Drugs Market Average Price (2021-2032)
  6. 2.3 Intestinal Anti-infective Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Neomycin
  9. 2.3.3 Berberine
  10. 2.3.4 Rifaximin
  11. 2.4 Intestinal Anti-infective Drugs by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Pharmacy
  14. 2.4.3 Hospital
  15. 2.4.4 Clinic
  16. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Intestinal Anti-infective Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Intestinal Anti-infective Drugs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Intestinal Anti-infective Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Intestinal Anti-infective Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Intestinal Anti-infective Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Intestinal Anti-infective Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Intestinal Anti-infective Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Intestinal Anti-infective Drugs, Established Date
  9. 3.9 Global Intestinal Anti-infective Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Chongqing Sino Biopharmaceutical Co., Ltd.
  2. 4.1.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Chongqing Sino Biopharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  6. 4.1.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Chongqing Laimi Pharmaceutical Co., Ltd.
  8. 4.2.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  12. 4.2.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Zhejiang Deer Pharmaceutical Co., Ltd.
  14. 4.3.1 Zhejiang Deer Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Zhejiang Deer Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  18. 4.3.5 Zhejiang Deer Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Yunnan Weihe Pharmaceutical Co., Ltd.
  20. 4.4.1 Yunnan Weihe Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Yunnan Weihe Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  24. 4.4.5 Yunnan Weihe Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Yangzhou Sanyao Pharmaceutical Co., Ltd.
  26. 4.5.1 Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Yangzhou Sanyao Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  30. 4.5.5 Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Tiansheng Pharmaceutical Group Co., Ltd.
  32. 4.6.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
  33. 4.6.2 Tiansheng Pharmaceutical Group Co., Ltd. Business Overview
  34. 4.6.3 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  36. 4.6.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments
  37. 4.7 Teyi Pharmaceutical Group Co., Ltd.
  38. 4.7.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
  39. 4.7.2 Teyi Pharmaceutical Group Co., Ltd. Business Overview
  40. 4.7.3 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  42. 4.7.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments
  43. 4.8 Sichuan Ziligong Pharmaceutical Co., Ltd.
  44. 4.8.1 Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Sichuan Ziligong Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  48. 4.8.5 Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
  50. 4.9.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  54. 4.9.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Shandong Xinhua Pharmaceutical Co., Ltd.
  56. 4.10.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  60. 4.10.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Nanjing Chengong Pharmaceutical Co., Ltd.
  62. 4.11.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Nanjing Chengong Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  66. 4.11.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Lingyuan Pharmaceutical Co., Ltd.
  68. 4.12.1 Lingyuan Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Lingyuan Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  72. 4.12.5 Lingyuan Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Jiangxi Pharmaceutical Co., Ltd.
  74. 4.13.1 Jiangxi Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Jiangxi Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  78. 4.13.5 Jiangxi Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
  80. 4.14.1 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  84. 4.14.5 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Jilin Jibang Pharmaceutical Co., Ltd.
  86. 4.15.1 Jilin Jibang Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Jilin Jibang Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  90. 4.15.5 Jilin Jibang Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Jilin Fukang Pharmaceutical Co., Ltd.
  92. 4.16.1 Jilin Fukang Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Jilin Fukang Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  96. 4.16.5 Jilin Fukang Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Hubei Hendi Pharmaceutical Co., Ltd.
  98. 4.17.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Hubei Hendi Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  102. 4.17.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
  104. 4.18.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  108. 4.18.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments
  109. 4.19 Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
  110. 4.19.1 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information
  111. 4.19.2 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Business Overview
  112. 4.19.3 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  114. 4.19.5 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Developments
  115. 4.20 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
  116. 4.20.1 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
  117. 4.20.2 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Business Overview
  118. 4.20.3 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
  120. 4.20.5 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments
  121. 4.21 Vox Nutrition
  122. 4.21.1 Vox Nutrition Company Information
  123. 4.21.2 Vox Nutrition Business Overview
  124. 4.21.3 Vox Nutrition Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio
  126. 4.21.5 Vox Nutrition Recent Developments
  127. 4.22 Teva Pharmaceuticals
  128. 4.22.1 Teva Pharmaceuticals Company Information
  129. 4.22.2 Teva Pharmaceuticals Business Overview
  130. 4.22.3 Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  132. 4.22.5 Teva Pharmaceuticals Recent Developments
  133. 4.23 Salix Pharmaceuticals
  134. 4.23.1 Salix Pharmaceuticals Company Information
  135. 4.23.2 Salix Pharmaceuticals Business Overview
  136. 4.23.3 Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
  138. 4.23.5 Salix Pharmaceuticals Recent Developments
  139. 4.24 Otto Chemie Pvt Ltd
  140. 4.24.1 Otto Chemie Pvt Ltd Company Information
  141. 4.24.2 Otto Chemie Pvt Ltd Business Overview
  142. 4.24.3 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio
  144. 4.24.5 Otto Chemie Pvt Ltd Recent Developments
  145. 4.25 Medikonda Nutrients
  146. 4.25.1 Medikonda Nutrients Company Information
  147. 4.25.2 Medikonda Nutrients Business Overview
  148. 4.25.3 Medikonda Nutrients Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio
  150. 4.25.5 Medikonda Nutrients Recent Developments
  151. 4.26 Botanic Healthcare
  152. 4.26.1 Botanic Healthcare Company Information
  153. 4.26.2 Botanic Healthcare Business Overview
  154. 4.26.3 Botanic Healthcare Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio
  156. 4.26.5 Botanic Healthcare Recent Developments
  157. 4.27 AdvaCare Pharma
  158. 4.27.1 AdvaCare Pharma Company Information
  159. 4.27.2 AdvaCare Pharma Business Overview
  160. 4.27.3 AdvaCare Pharma Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio
  162. 4.27.5 AdvaCare Pharma Recent Developments
5 Global Intestinal Anti-infective Drugs Market Scenario by Region
  1. 5.1 Global Intestinal Anti-infective Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Intestinal Anti-infective Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Intestinal Anti-infective Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Intestinal Anti-infective Drugs Sales by Region: 2027-2032
  5. 5.3 Global Intestinal Anti-infective Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Intestinal Anti-infective Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Intestinal Anti-infective Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Intestinal Anti-infective Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Intestinal Anti-infective Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Intestinal Anti-infective Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Intestinal Anti-infective Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Intestinal Anti-infective Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Intestinal Anti-infective Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Intestinal Anti-infective Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Intestinal Anti-infective Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Intestinal Anti-infective Drugs Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Intestinal Anti-infective Drugs Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Intestinal Anti-infective Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Intestinal Anti-infective Drugs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Intestinal Anti-infective Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Intestinal Anti-infective Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Intestinal Anti-infective Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Intestinal Anti-infective Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Intestinal Anti-infective Drugs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Intestinal Anti-infective Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Intestinal Anti-infective Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Intestinal Anti-infective Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Intestinal Anti-infective Drugs Value Chain Analysis
  2. 8.1.1 Intestinal Anti-infective Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Intestinal Anti-infective Drugs Production Mode & Process
  5. 8.2 Intestinal Anti-infective Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Intestinal Anti-infective Drugs Distributors
  8. 8.2.3 Intestinal Anti-infective Drugs Customers
9 Global Intestinal Anti-infective Drugs Analyzing Market Dynamics
  1. 9.1 Intestinal Anti-infective Drugs Industry Trends
  2. 9.2 Intestinal Anti-infective Drugs Industry Drivers
  3. 9.3 Intestinal Anti-infective Drugs Industry Opportunities and Challenges
  4. 9.4 Intestinal Anti-infective Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst